Abstract -DNA microarray-based gene expression profiles have been established for a variety of adult cancers. This paper addresses application of an artificial neural network (ANN) with leave-oneout testsing and 8-fold cross-validation for analyzing DNA microarray data to identify genes predictive of recurrence after prostatectomy. Among 725 genes screened for ANN input, a 16-gene model resulted in 99-100% diagnostic sensitivity and specificity: DGCR5,
I. Introduction
Prostate cancer is the 2nd leading cause of cancer mortality among US males [1] . For locally confined cancer, curative treatment includes radical prostatectomy [2, 3] and radiotherapy [4] [5] [6] [7] . Following prostatectomy, it is expected that serum levels of prostate specific antigen (PSA) remain fixed below a level of 0.2 ng/ml. However, approximately 15-35% of patients experience PSA (biochemical) recurrence defined as two or more successive follow-up values of PSA>0.2 ng/ml more than 30 days post-surgery [8] [9] [10] [11] . Early biochemical recurrence occurring before 1 year postsurgery is strongly associated with metastatic disease in approximately 75% of male patients [12] . However, clinical and pathological factors are imperfect predictors of biochemical recurrence. Thus, it is of interest to augment clinical information with prognostic information derived from molecular markers of aggressive disease.
Research for identifying biomarkers as a supplement to clinical information for prostate cancer has increased tremendously over the last decade. With regard to gene expression studies on recurrence, Lapointe et al identified a set of 23 genes whose expression levels were either positively or negatively associated with early recurrence in a set of 7 prostate cancers with early recurrence and 22 non-recurrent tumors [13] . Singh et al [14] studied gene expression of 12,600 genes in 21 prostate cancers (8 recurrent, 13 non-recurrent), and defined a set of 5 genes whose expression levels resulted in 90% accuracy of class prediction. Glinsky et al [15] performed additional xenograftbased analyses on the same data set and derived three five-gene models resulting in 95% classification accuracy. Lastly, Yu and colleagues [16] looked at a 70-gene leaveone-out classification model for 29 aggressive tumors and 37 non-aggressive tumors and obtained 86% classification accuracy.
There is growing interest in the application of ANNs in microarray analysis [17] [18] [19] [20] [21] . The majority of these papers conclude unique and superior classification results obtained with ANNs when compared with other classifiers. In this report, we applied an artificial neural network (ANN) to identify microarray-based genes with the greatest class-specific sensitivity for predicting PSA recurrence of prostate cancer. Two-color oligonucleotide microarrays were employed for generating patient gene expression profiles. The set of genes identified may ultimately be used to provide additional prognostic information in men with prostate cancer that will be useful for evaluation of prognosis and treatment planning.
II. Methods

A. Microarray Samples and Gene Ranking
We used a total of 32 arrays for prostate cancer cases undergoing radical prostatectomy. RNA was extracted from the peripheral zone in tissue with greater than 70% tumor pathology. Two-color 21k gene oligonucleotide arrays were hybridized and scanned for 15 cases which experienced post-surgical PSA recurrence <1 year ("poor outcome") and 17 cases which remained recurrent-free more than 5 y ("good outcome") post-surgery. From 21,329 genes, we identified 5,757 which had at least 95% informative spots (G and R signal-to-noise ratio>2) within each class. The non-parametric Mann-Whitney U test, which approximates the Gini diversity index [23] , of the ChipST2C program (http://www.chipst2c.org) was used to identify 725 genes with significant rank differences (P <0.01) in expression between poor and good outcome. Gene ranking resulted in a 32 × 725(A × G) E matrix of standardized expression, where A(a = 1, 2, . . . , 32) is the number of samples and G(g = 1, 2, . . . , 725) is the number of genes.
B. Dimensional Reduction
Dimensional reduction using k-means cluster analysis and principal component analysis (PCA) was performed with the ANNChip computer program (http://www.chipst2c.org). The objective for running k-means and PCA was to reduce the number of input nodes to be clamped to the ANN during training. In addition, individual gene expression values were mapped back to the k-means centers and PC scores by use of k-means scores and PC score coefficients. During k-means clustering in ANNChip, the optimum number of k clusters occurs when the ratio of the smallest between-cluster distance to total mean-square error (grand total of error between each gene and its mean vector) is the greatest. K-means cluster analysis resulted in a 32 × 27(A × K) M matrix of cluster centers, where A(a = 1, 2, . . . , 32) is the number of samples and K(k = 1, 2, . . . , 27) is the number of centers. Figure 1 shows a countour plot of the M matrix of 27 centers for the 32 arrays. Because the ANN is trained on samples with 27 input values representing the k=27 clusters, the gene expression profiles over 32 arrays needed to be mapped to the average expression within the 27 clusters by using "k-means scores."
The k-means score which maps gene g to center k is determined as
where x g is the standardized expression vector for gene g, m k is the mean vector for center k, x g − m k is the Euclidean distance between expression for gene g and center k, and µ k and σ k are the average and standard deviation of distances x g − m k between all genes and center k. This was repeated for each cluster center to yield a 725 × 27(G × K) Z matrix of k-means scores. During PCA dimensional reduction, the top 10 eigenvalues explaining 73.4% of total variation were extracted from the 725 × 725(G × G) correlation matrix R. PCA resulted in a 32 × 10(A × P ) F matrix of PC scores, where A(a = 1, 2, . . . , 32) is the number of samples and P (p = 1, 2, . . . , 10) is the number of PCs. Figure 2 illustrates a countour plot of the F matrix of 10 PCs for the 32 arrays. Figure 3 shows the 725 × 27(G × K) Z matrix of k-means scores and the 725 × 10(G × P ) W matrix of PC score coefficients, which map expression back to the k-means centers and PC scores, respectively.
C. ANN Architecture
A multilayer perceptron with back-propagation learning was employed as the ANN (Figure 4 ). When ANN training 
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a Matrices M and F used for training ANN. b Applied weights after last training epoch against matrices Z and W looping over all genes once to determine E g c and S g c . c Class membership was predicted after retraining ANN with standardized expression matrix E for genes identified during RFE. M is the matrix of k-means centers. F is the matrix of PC scores. Z is the matrix of k-means scores. W is the matrix of PC score score coefficients. E is the matrix of standardized expression. A is the number of arrays, ( a = 1 , 2 , . . . , A) . K is the number of k-means cluster centers, ( k = 1 , 2 , . . . , K) . P is the number of PCs, ( p = 1 , 2 , . . . , P ) . G is the number of genes, ( g = 1 , 2 , . . . , G) . During RFE, G = 725 , whereas during prediction
was based on k-means centers, we clamped rows of the A × K M matrix of cluster centers to the input nodes (i.e., x a = m a , a = 1, 2, . . . , 32). Whereas when ANN training was based on PCA, we clamped rows of the A×P F matrix of PC scores to the input nodes (i.e., x a = f a , a = 1, 2, . . . , 32). The number of hidden nodes was equal to 40% of the number of input nodes. Connection weights w ih ij between the input and hidden layer and w ho jc between hidden and output layers were initialized with random uniform variates in the range [-0.5,0.5]. Node output v j at the hidden layer were based on the logistic activation function 1/(1 + exp(−u j )), where u j = x i w ih ij , while node outputst c at the output layer were based on the softmax function exp(y c )/ exp(y l ), where y c = v j w ho jc . Mean square error (MSE) for each sample was determined as 0.5 c (t c −t c ) 2 , wheret c is the predicted target probability of each sample being in class c and t c is the true class probability of each sample, set to zero or unity. After each sample was transmitted through the ANN, backpropagation learning was performed sequentially updating weights one sample at a time. A total of 25 epochs was performed for each model, with 32 cycles (samples) per epoch. (Models using 5000 epochs were evaluated and neither increased overtraining or diversion of the gradient descent toward local maxima were observed). The ANN model fitting approach combined leave-one-out testing with 8-cross-validation. Arrays in the validation group were not used for training and only for prediction of class outcome, while the remaining samples were used for training the ANN. Last, we used a learning rate of = 0.5, a steadily decreasing weight decay γ, and momentum of α = 0.5. 
D. ANN Recursive Feature Elimination
In order to gauge the influence of each gene on the classification, target outputst g c for each gene were calculated during the last sweep of every model using the last known weights and setting the input nodes x i equal to either the 1 × K row vector of k-means scores z g for each gene or the 1 × P row vector w g of PC score coefficients for each gene. It warrants noting that the ANN was not retrained here, but rather gene-specific values oft g c were determined by applying the last known weights to gene-specific row vectors of Z or W, which map the genes back to the original M and F matrices used for training. a) Gene Selection with Maximum Sensitivity: The average gene-class-specific sensitivity [24] of each gene was determined as
where g is the gene, c is the class, n is the number of input nodes based on n = K and x g = z g if the ANN was trained with k-means centers based on M, or n = P and x g = w g if the ANN was trained with PC scores based on F (Table  I) . Class-specific sensitivities for each gene were summed over all 256 models and then sorted in descending order. b) Gene Selection with Minimum Error: In addition to RFE based on sensitivity, we also calculated the geneclass-specific mean square error during the last sweep, using the recomputed values oft g c described above. Analogously, we derived lists of genes for which each class was represented equally by genes having the lowest gene-classspecific MSE. Recall that the predicted class targett 
E. Generating Lists of Selected Genes
A modular approach was employed for generating the list of genes identified during RFE. Lists were divided uniformly into genes that best discriminated each outcome class, depending on whether the selection criterion was minimum gene-class-specific MSE or maximum gene-classspecific sensitivity. The total number of genes in a list was based on powers of 2 multiplied by the number of classes, such that the list was uniformly loaded with genes that best discriminated each class. As an example, in this two class study, gene selection lists contained a total of 2, 4, 8, 16, 32, or 64 genes with half of the genes having the total maximum sensitivity (or least error) for the poor outcome and half having the maximum sensitivity (or least error) for the good outcome class.
F. ANN Training with Selected Gene Expression Profiles
After recursive feature identification, we trained the ANN models with the actual standardized values of expression for each list of 2, 4, 8, 16, 32, or 64 genes identified. Expression for each gene was standardized over the arrays (using array-specific mean and s.d.) ANN clamping involved use of the rows of the standardized expression matrix E such that x a = e a ( Table I ). The number of hidden nodes was equal to 40% of the number of input nodes. For example, for 64 genes (features) and 2 outcome classes a 64-26-2 network was employed. During runs with actual gene expression profiles, we assessed accuracy and, the proportion of between-gene correlation coefficients that were significant (p ≤ 0.01).
G. ANN Pseudocode
The following provides the ANN algorithm used: 1) for leaveout ← 1 to #Arrays 2) Randomly assign each array into O equal partitions 
• if array / ∈ o then 'training array t = t + 1 'increment cycle ∆w 
III. Results
Figures 5 and 6 show the MSE for ANN training based on standardized expression profiles for the top 4 genes and 16 genes, respectively, identified after k-means dimensional reduction and maximum sensitivity used as a criterion for RFE. In Figures 5 and 6 , red denotes training MSE while blue denotes validation MSE. In Figure 5 , one can notice the overtraining that occurred as a result of ANN training with expression profiles for only 4 genes. When the ANN was trained with expression profiles of the top 16 genes (Figure 6 ), however, there was no apparent overtraining for the 25 epochs used.
Tables II and III list diagnostic sensitivity and specificity results of ANN modeling for the poor and good outcome class predictions, respectively. Recall that sensitivity is defined as the probability of correctly predicting that an array is in class A given that the array is truly from diagnostic class A. Specificity is defined as the probability of correctly assigning an array to a class other than A given that the array is truly not in class A. For the calibration run using the k-means centers and PC scores from all 725 probes, sensitivity and specificity ranged from 90-100% for both outcome groups. For runs using standardized expression for the top genes identified, at 2 genes and more, sensitivity and specificity steadily ramped up from 70-80% for 2 genes to the greatest values in the 90% range for 64 genes. Interestingly, for k-means cluster analysis dimensional reduction, the maximum sensitivity and specificity for both outcomes was observed for 16-gene models. However, for PCA dimensional reduction, the greatest values of sensitivity and specificity were observed among 64-gene models. These results show that, for the training data considered, use of k-means cluster analysis for data pre-processing, followed by cross-validation and leave-one-out testing can provide remarkably high screening diagnostics exceeding 95%. The 16 genes identified after k-means dimensional reduction and maximum sensitivity for RFE that resulted in a sensitivity of 1.0 (in Table  II) were DGCR5, FLJ10618, RIS1, PRO1855, ABCB9, AK057203, GOLGA5, HARS, AK024152, HEP27, PPIA, SNRPF, SULT1A3, SECTM1, EIF4EBP1, and S71435. These are also highlighted in bold in Table IV in the 64-gene model. Tables IV and V list the top 64 genes selected by RFE for the 64-gene models for dimensional reduction with k-means cluster analysis and PCA, respectively. It was interesting to learn that the 64 genes listed were not always the most significant genes based on the Mann-Whitney U test used for the gene ranking. Although not shown, the majority of the genes identified were among the least significant (rank >300). This reflects the generalizability of ANN models for which there is a preference to select not the most significant genes, but rather those which simultaneously maximize the screening diagnostics (sensitivity and specificity). The genes listed in Tables IV and V became available at the time of writing, so they are now being mined for their roles in cancer (i.e., prostate), GO groups, PFAM familes, secretion signals, transcription factor binding sites in promoters, and protein interactions, Table IV. etc. Figure 7 illustrates the significant positive and negative between-gene correlation of expression for the 64-gene models. Red represents significant (p < 0.01) positive correlation coefficients, while blue denotes significant (p < 0.01) negative correlation coefficients. Panel 4A for kmeans dimensional reduction and min{E Overall, one can note the reduced significant positive correlation for RFE with maximum sensitivity (panels 4B and 4D), which is accentuated for k-means dimensional reduction (panel 4B). This is in good agreement with results obtained in our previous work using simulated and empirical expression data from the public domain [24] .
IV. Discussion and Conclusion
The purpose of this study was to compare diagnostic screening results (sensitivity and specificity) and betweengene correlation across dimensional reduction and RFE methods used. The ANN analysis results obtained demonstrate that diagnostic sensitivity and specificity in the range 99-100% was obtained when using k-means dimensional reduction and maximum sensitivity for RFE for a 16-gene model. On the other hand, for PCA dimensional reduction, diagnostic screening results were in the 70-80% range for 16 genes. In addition, dimensional reduction with k-means cluster analysis and RFE with maximum sensitivity resulted in the least amount of significant positive between-gene correlation. We are currently trying to understand the biological relevance of the 64 genes identified with the various methods. The majority of this effort involves GO mining and development of transcription factor networks and review by biologists to determine any differences in the computational results. We will eventually compare results with support vector machines, and soft computing methods, which provide alternative approaches for optimizing decision boundaries between classes.
TABLE IV
Genes identified in 64-gene models for k-means cluster analysis dimensional reduction. Genes in bold resulted in greatest diagnostic sensitivity and specificity among all other gene models, see Table II . DKFZp434N0650  KIAA0878  IRF2  PRKCBP1  TMEPAI  LOC56899  FLJ11585  RAD51C  GNG8  C20orf67  ZNF302  AK055723  SCRIB  SLC11A1  NPHP1  FLJ20040  SCAD-SRL  AK022635  KIAA1522  IL3  FLJ10986  ASK  MGC14833  AK023312  PIG6  MPDU1  NM 053284  AJ420416  CABP2  CCNB2  AK056890  PRSC  DUSP10  MYBL2  FLJ10521  BICD1  FLJ20778 MTCP1  APOB  DMWD  DHPS  AK025806  AK026657  BRF2  SNRPG  SYN2  TNFAIP3  NR6A1  AK027185  AK026984  MGC3032  SNX4  COX7A2  FLJ20081  K-ALPHA-1  LOC57862  MPDU1  CACNG5  EIF4EL3  FLJ00052  BMPR1A  AB051444  AK055589  OT7T022  AK057233  PVALB  KIAA1093  AC008050  PRO1073  CNNM3  AF052181  DDAH2  AK026439  FLJ10043  U79289  AL136753  AJ420528  AK056119  FLJ10900  PP15  BYSL  X55777  PIP5K1C  PIPPIN  ADM  FLJ14442 TABLE V Genes identified in 64-gene models for PCA dimensional reduction. PRO1073  IRF2  POLR2J  DKFZP564P1916  AK026657  SRP54  SULT1A3  BC007749  MGC5356  TDPGD  SAFB  GLRX2  AK024289  FLJ10675  SNRPF  MMP7  DKFZp762O076  AK027155  SNRPG  AK023744  PGLYRP  PRO0297  AK023312  COVA1  BMPR1A  AL133086  AK026704  HOXA7  FLJ13942  ZNF197  DRIL1  EEA1  MRPL17  PHYHIP  BAZ1A  RAB4B  AK055603  CGI-57  MGC15730  NRF1  DGCR5  GRP58  FLJ20313  ZNF275  PSMD3  RNF28  DHPS  FLJ23306  AL133050  PP1044  AK022294  BC002782  SAP18  AK022134  AK055203  AK000435  BC016154  AK023945  WNT7A  KIFAP3  FLJ20442  GGT1  KRTHA4  FLJ14855  IRF2  POLR2J  DKFZP564P1916  PRO1073  SRP54  SULT1A3  BC007749  AK026657  TDPGD  SAFB  GLRX2  AK024289  MMP7  SNRPF  FLJ10675  SNRPG  AK027155  MGC5356  AK023744  DKFZp762O076  HOXA7  AK023312  EEA1  PGLYRP  PRO0297  BMPR1A  AL133086  AK055603  COVA1  AK026704  ZNF197  FLJ20313  NRF1  MRPL17  GRP58  FLJ13942  RAB4B  DHPS  PHYHIP  DRIL1  FLJ23306  BAZ1A  KIFAP3  AK055203  CGI-57  PGCP  ZNF275  KPTN  BC002782  MGC15730  AK000435  BC016154  AK022134  AK022294  GGT1  FLJ20442  RNF28  WNT7A  FLJ14855  PSMD3  PP1044  AL133050  AK023945 
